Combined administration of cerebrolysin and donepezil induces plastic changes in prefrontal cortex in aged mice

Synapse

Volumn 66, Issue 11, 2012, Pages 938-949

  Alcántara González, Faviola ^a,b   Mendoza Perez, Claudia Rebeca ^a   Zaragoza, Néstor ^a   Juarez, Ismael ^a   Arroyo García, Luis Enrique ^a   Gamboa, Citlalli ^a   De La Cruz, Fidel ^b   Zamudio, Sergio ^b   Garcia Dolores, Fernando ^c   Flores, Gonzalo ^a  

^a BENEMÉRITA UNIVERSIDAD AUTÓNOMA DE PUEBLA   (Mexico)

^b INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^c HOSPITAL REGIONAL 1 DE OCTUBRE   (Mexico)

Author keywords

Alzheimer's disease; Cerebrolysin; Dendritic morphology; Donepezil; Golgi Cox stain; Spine density

Indexed keywords

CEREBROLYSIN; DONEPEZIL;

ANIMAL EXPERIMENT; ARTICLE; BRAIN REGION; CELL STRUCTURE; CONTROLLED STUDY; DENDRITE; DENTATE GYRUS; GOLGI STAIN; HIPPOCAMPUS; LEARNING; LOCOMOTION; MALE; MEMORY; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL;

AGING; AMINO ACIDS; ANIMALS; DENDRITIC SPINES; DRUG SYNERGISM; INDANS; MALE; MICE; MOTOR ACTIVITY; NEURONAL PLASTICITY; NOOTROPIC AGENTS; PIPERIDINES; PREFRONTAL CORTEX; PYRAMIDAL CELLS;

EID: 84866160576     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.21588     Document Type: Article

References (104)

1. Akaike A. 2006. Preclinical evidence of neuroprotection by cholinesterase inhibitors. Alzheimer Dis Assoc Disord 20: S8-S11.
2. Akaike A, Takada-Takatori Y, Kume T, Izumi Y. 2010. Mechanisms of neuroprotective effects of nicotine and acetylcholinesterase inhibitors: Role of α4 and α7 receptors in neuroprotection. J Mol Neurosci 40: 211-216.
3. Alcántara-González F, Juárez I, Solís O, Martínez-Téllez RI, Camacho-Ábrego I, Masliah E, Mena R, Flores G. 2010. Enhanced dendritic spine number of neurons of the prefrontal cortex, hippocampus, and nucleus accumbens in old rats after chronic donepezil administration. Synapse 64: 786-793.
4. Allendoerfer KL, Cabelli RJ, Escandon E, Kaplan DR, Nikolics K, Shatz CJ. 1994. Regulation of neurotrophin receptors during the maturation of the mammalian visual system. J Neurosci 14: 1795-1811.
5. Alquicer G, Morales-Medina JC, Quirion R, Flores G. 2008. Postweaning social isolation enhances morphological changes in the neonatal ventral hippocampal lesion rat model of psychosis. J Chem Neuroanat 35: 179-187.
6. Álvarez XA, Lombardi VR, Fernández-Novoa L, García M, Sampedro C, Cagiao A, Cacabelos R, Windisch M. 2000. Cerebrolysin reduces microglial activation in vivo and in vitro: A potential mechanism of neuroprotection. J Neural Transm Suppl 59: 281-292.
7. Álvarez A, Cacabelos R, Sanpedro C, Garcia-Fantini M, Aleixandre M. 2007. Serum TNF-alpha levels are increased and correlate negatively with free IGF-I in Alzheimer disease. Neurobiol Aging 28: 533-536.
8. Alvarez XA, Cacabelos R, Sampedro C, Couceiro V, Aleixandre M, Vargas M, Linares C, Granizo E, García-Fantini M, Baurecht W, Doppler E, Moessler H. 2011. Combination treatment in Alzheimer's disease: Results of a randomized, controlled trial with cerebrolysin and donepezil. Curr Alzheimer Res 8: 583-591.
9. Álvarez XA, Fuentes P. 2011. Cerebrolysin in Alzheimer's disease. Drugs Today (Barc) 47: 487-513.
10. Andin J, Enz A, Gentsch C, Marcusson J. 2005. Rivastigmine as a modulator of the neuronal glutamate transporter rEAAC1 mRNA expression. Dement Geriatr Cogn Disor 19: 18-23.
11. Atkinson-Leadbeater K, McFarlane S. 2011. Extrinsic factors as multifunctional regulators of retinal ganglion cell morphogenesis. Dev Neurobiol 71: 1170-1185.
12. Autio H, Mätlik K, Rantamäki T, Lindemann L, Hoener MC, Chao M, Arumäe U, Castrén E. 2011. Acetylcholinesterase inhibitors rapidly activate Trk neurotrophin receptors in the mouse hippocampus. Neuropharmacology 61: 1291-1296.
13. Bergstrom HC, McDonald CG, French H, Smith RF. 2008. Continuous nicotine administration produces selective, age-dependent structural alteration of pyramidal neurons from prelimbic cortex. Synapse 62: 31-39.
14. Bertram L. 2009. Alzheimer's disease genetics current status and future perspectives. Int Rev Neurobiol 84: 167-184.
15. Bertram L, Tanzi RE. 2010. Alzheimer disease: New light on an old CLU. Nat Rev Neurol 6: 11-13.
16. Bordji K, Becerril-Ortega J, Buisson A. 2011. Synapses, NMDA receptor activity and neuronal Aβ production in Alzheimer's disease. Rev Neurosci 22: 285-294.
17. Brown RW, Kolb B. 2001. Nicotine sensitization increases dendritic length and spine density in the nucleus accumbens and cingulate cortex. Brain Res 899: 94-100.
18. Chen H, Tung YC, Li B, Iqbal K, Grundke-Iqbal I. 2007. Trophic factors counteract elevated FGF-2-induced inhibition of adult neurogenesis. Neurobiol Aging 28: 1148-1162.
19. Chen X, Fu W, Tung CE, Ward NL 2009. Angiopoietin-1 induces neurite outgrowth of PC12 cells in a Tie2-independent, beta1-integrin-dependent manner. Neurosci Res 64: 348-354.
20. Collerton, D. 1986. Cholinergic function and intellectual decline in Alzheimer's disease. Neurosci 19: 1-28.
21. Craig LA, Hong NS, McDonald RJ. 2011. Revisiting the cholinergic hypothesis in the development of Alzheimer's disease. Neurosci Biobehav Rev 35: 1397-1409.
22. Crews L, Masliah E. 2010. Molecular mechanisms of neurodegeneration in Alzheimer's disease. Hum Mol Genet 19: R12-R20.
23. Doppler E, Rockenstein E, Ubhi K, Inglis C, Mante M, Adame A, Crews L, Hitzl M, Moessler H, Masliah E. 2008. Neurotrophic effects of cerebrolysin in the Mecp2(308/Y) transgenic model of Rett syndrome. Acta Neuropathol 116: 425-437.
24. Eder P, Reinprecht I, Schreiner E, Skofitsch G, Windisch M. 2001. Increased density of glutamate receptor subunit 1 due to cerebrolysin treatment: An immunohistochemical study on aged rats. Histochem J 33: 605-612.
25. Fargali S, Sadahiro M, Jiang C, Frick AL, Indall T, Cogliani V, Welagen J, Lin WJ, Salton SR. 2012. Role of neurotrophins in the development and function of neural circuits that regulate energy homeostasis. J Mol Neurosci DOI: 10.1007/s12031-012-9790-9.
26. Farlow MR, Cummings JL. 2007. Effective pharmacologic management of Alzheimer's disease Am J Med 120: 388-397.
27. Flores G, Alquicer G, Silva-Gomez AB, Zaldivar G, Stewart J, Quirion R, Srivastava LK. 2005. Alterations in dendritic morphology of prefrontal cortical and nucleus accumbens neurons in postpubertal rats after neonatal excitotoxic lesions of the ventral hippocampus. Neuroscience 133: 463-470.
28. Francis-Turner L, Valouskova V. 1996. Nerve growth factor and nootropic drug Cerebrolysin but not fibroblast growth factor can reduce spatial memory impairment elicited by fimbria-fornix transection: Short-term study. Neurosci Lett 202: 193-196.
29. Fumagalli F, Racagni G, Riva MA. 2006. The expanding role of BDNF: A therapeutic target for Alzheimer's disease? Pharmacogenomics J 6: 8-15.
30. Gamboa C, Ortega A. 2002. Insulin-like growth factor-1 increases activity and surface levels of the GLAST subtype of glutamate transporter. Neurochem Int 40: 397-403.
31. Gasperi M, Castellano AE. 2010. Growth hormone/insulin-like growth factor I axis in neurodegenerative diseases. J Endocrinol Invest 33: 587-591.
32. Gibb R, Kolb B. 1998. A method for vibratome sectioning of Golgi-Cox stained whole rat brain. J Neurosci Methods 79: 1-4.
33. Ginsberg SD, Wuu J, Counts SE, Mufson EJ. 2006. Down regulation of trk but not p75NTR gene expression in single cholinergic basal forebrain neurons mark the progression of Alzheimer's disease. J Neurochem 97: 475-487.
34. Gonzalez CL, Gharbawie OA, Whishaw IQ, Kolb B. 2005. Nicotine stimulates dendritic arborization in motor cortex and improves concurrent motor skill but impairs subsequent motor learning. Synapse 55: 183-191.
35. Gschanes A, Windisch M. 1999. Early postnatal treatment with peptide preparations influences spatial navigation of young and adult rats. Behav Brain Res 100: 161-166.
36. Gutmann B, Hutter-Paier B, Skofitsch G, Windisch M, Gmeinbauer R. 2002. In vitro models of brain ischemia: The peptidergic drug cerebrolysin protects cultured chick cortical neurons from cell death. Neurotox Res 4: 59-65.
37. Hardy J, Selkoe DJ. 2002. The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science 297: 353-356.
38. Hartbauer M, Hutter-Paier B, Skofitsch G and Windisch M. 2001. Antiapoptotic effects of the peptidergic drug cerebrolysin on primary cultures of embryonic chick cortical neurons. J Neural Transm 108: 459-473.
39. Hutter-Paier B, Grygar E, Windisch M. 1996. Death of cultured telencephalon neurons induced by glutamate is reduced by the peptide derivative Cerebrolysin. J Neural Transm Suppl 47: 267-273.
40. Hutter-Paier B, Grygar E, Frühwirth M, Temmel I, Windisch M. 1998. Further evidence that cerebrolysin protects cortical neurons from neurodegeneration in vitro. J Neural Transm Suppl 53: 363-372.
41. Hwang J, Hwang H, Lee HW, Suk K. 2010. Microglia signaling as a target of donepezil. Neuropharmacology 58: 1122-1129.
42. Iqbal K, Liu F, Gong CX, Alonso Adel C, Grundke-Iqbal I. 2009. Mechanisms of tau-induced neurodegeneration. Acta Neuropathol 118: 53-69.
43. Ittner LM, Gotz J. 2011. Amyloid-beta and tau-a toxic pas de deux in Alzheimer's disease. Nat Rev Neurosci 12: 65-72.
44. Jaworski J, Spangler S, Seeburg DP, Hoogenraad CC, Sheng M. 2005. Control of dendritic arborization by the phosphoinositide-3-kinase-Akt-mammalian target of rapamycin pathway. J Neurosci 25: 11300-11312.
45. Juarez I, Gratton A, Flores G. 2008. Ontogeny of altered dendritic morphology in the rat prefrontal cortex, hippocampus and nucleus accumbens following caesarean delivery and birth anoxia. J Comp Neurol 507: 1734-1747.
46. Juárez I, González DJ, Mena R, Flores G. 2011. The chronic administration of cerebrolysin induces plastic changes in the prefrontal cortex and dentate gyrus in aged mice. Synapse 65: 1128-1135.
47. Kapogiannis D, Mattson MP. 2011. Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimer's disease. Lancet Neurol 10: 187-198.
48. Kolb B, Forgie M, Gibb R, Gorny G, Rowntree S. 1998. Age, experience and the changing brain. Neurosci Biobehav Rev 22: 143-159.
49. Kotani S, Yamauchi T, Teramoto T, Ogura H. 2008. Donepezil, an acetylcholinesterase inhibitor, enhances adult hippocampal neurogenesis. Chem Biol Interact 175: 227-230.
50. Krizman-Genda E, González MI, Zelenaia O, Robinson MB. 2005. Evidence that Akt mediates platelet-derived growth factor-dependent increases in activity and surface expression of the neuronal glutamate transporter, EAAC1. Neuropharmacology 49: 872-882.
51. Leyhe T, Stransky E, Eschweiler GW, Buchkremer G, Laske C. 2008. Increase of BDNF serum concentration during donepezil treatment of patients with early Alzheimer's disease. Eur Arch Psychiatry Clin Neurosci 258: 124-128.
52. Mallory M, Honer W, Hsu L, Johnson R, Rockenstein E, Masliah E. 1999. In vitro synaptotrophic effects of Cerebrolysin in NT2N cells. Acta Neuropathol 97: 437-446.
53. Martínez-Téllez R, Gómez-Villalobos MJ, Flores G. 2005. Alteration in dendritic morphology of cortical neurons in rats with diabetes mellitus induced by streptozotocin. Brain Res 1048: 108-115.
54. Martínez-Téllez RI, Hernández-Torres E, Gamboa C, Flores G. 2009. Prenatal stress alters spine density and dendritic length of nucleus accumbens and hippocampus neurons in rat offspring. Synapse 63: 794-804.
55. McGeer EG, McGeer PL. 2011. Neuroinflammation in Alzheimer's disease and mild cognitive impairment: A field in its infancy. J Alzheimers Dis 19: 355-361.
56. Mello NK. 2010. Hormones, nicotine, and cocaine: clinical studies. Horm Behav 58: 57-71.
57. Mosconi L, Pupi A, De Leon MJ. 2008. Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer's disease. Ann NY Acad Sci 1147: 180-195.
58. Mufson EJ, Counts SE, Fahnestock M, Ginsberg SD. 2007. Cholinotrophic molecular substrates of mild cognitive impairment in the elderly. Curr Alzheimer Res 4: 340-350.
59. Narimatsu N, Harada N, Kurihara H, Nakagata N, Sobue K, Okajima K. 2009. Donepezil improves cognitive function in mice by increasing the production of insulin-like growth factor-I in the hippocampus. J Pharmacol Exp Ther 330: 2-12.
60. Nelson PT, Braak H, Markesbery WR. 2009. Neuropathology and cognitive impairment in Alzheimer disease: A complex but coherent relationship. J Neuropathol Exp Neurol 68: 1-14.
61. Obermayr RP, Mayerhofer L, Knechtelsdorfer M, Mersich N, Huber ER, Geyer G, Tragl KH. 2005. The age-related down-regulation ofthe growth hormone/insulin-like growth factor-1 axis in the elderly male is reversed considerably by donepezil, a drug for Alzheimer's disease. Exp Gerontol 40: 157-163.
62. Oda T, Kume T, Katsuki H, Niidome T, Sugimoto H, Akaike A. 2007. Donepezil potentiates nerve growth factor-induced neurite outgrowth in PC12 cells. J Pharmacol Sci 104: 349-354.
63. Ogura H, Kosasa T, Kuriya Y, Yamanishi Y. 2000. Comparison of inhibitory activities of donepezil and other cholinesterase inhibitors on acetylcholinesterase and butyrylcholinesterase in vitro. Methods Find Exp Clin Pharmacol 22: 609-614.
64. Onose G, Mureşanu DF, Ciurea AV, Chendreanu CD, Mihaescu AS, Mardare DC, Andone I, Spânu A, Popescu C, Dumitrescu A, Popescu M, Grigorean V, Ungur B, Marinescu F, Colibǎşeanu I, Onose L, Haras M, Sandu A, Spircu T. 2009. Neuroprotective and consequent neurorehabilitative clinical outcomes, in patients treated with the pleiotropic drug cerebrolysin. J Med Life 2: 350-360.
65. Palop JJ, Mucke L. 2010. Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease: From synapses toward neural networks. Nat Neurosci 13: 812-818.
66. Paxinos G, Watson C. 1986. The rat brain in stereotaxic coordinates, 2nd ed. New York: Academic Press.
67. Piriz J, Muller A, Trejo JL, Torres-Aleman I. 2011. IGF-I and the aging mammalian brain. Exp Gerontol 46: 96-99.
68. Reinprecht I, Gschanes A, Windisch M, Fachbach G. 1999. Two peptidergic drugs increase the synaptophysin immunoreactivity in brains of 24-month-old rats. Histochem J 31: 395-401.
69. Riley C, Hutter-Paier B, Windisch M, Doppler E, Moessler H, Wronski R. 2006. A peptide preparation protects cells in organotypic brain slices against cell death after glutamate intoxication. J Neural Transm 113: 103-110.
70. Robinson TE, Gorny G, Mitton E, Kolb B. 2001. Cocaine self-administration alters the morphology of dendrites and dendritic spines in the nucleus accumbens and neocortex. Synapse 39: 257-266.
71. Robinson TE, Kolb B. 1997. Persistent structural modifications in nucleus accumbens and prefrontal cortex neurons produced by previous experience with amphetamine. J Neurosci 17: 8491-8497.
72. Robinson TE, Kolb B. 1999. Alterations in the morphology of dendrites and dendritic spines in the nucleus accumbens and prefrontal cortex following repeated treatment with amphetamine or cocaine. Eur J Neurosci 11: 1598-1604.
73. Rockenstein E, Torrance M, Mante M, Adame A, Paulino A, Rose JB, Crews L, Moessler H, Masliah E. 2006. Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease. J Neurosci Res 83: 1252-1261.
74. Rockenstein E, Mante M, Adame A, Crews L, Moessler H, Masliah E. 2007. Effects of cerebrolysin on neurogenesis in APP transgenic model of Alzheimer's disease. Acta Neuropathol 113: 265-275.
75. Sanchez F, Gomez-Villalobos MJ, Juarez I, Quevedo L, Flores G. 2011. Dendritic morphology of neurons in medial prefrontal cortex, hippocampus, and nucleus accumbens in adult SH rats. Synapse 65: 198-206.
76. Schauer E, Wronski R, Patockova J, Moessler H, Doppler E, Hutter-Paier B, Windisch M. 2006. Neuroprotection of cerebrolysin in tissue culture models of brain ischemia: Post lesion application indicates a wide therapeutic window. J Neural Transm 113: 855-868.
77. Schiltz CA, Kelley AE, Landry CF. 2007. Acute stress and nicotine cues interact to unveil locomotor arousal and activity-dependent gene expression in the prefrontal cortex. Biol Psychiatry 61: 127-135.
78. Schindowski K, Belarbi K, Buee L. 2008. Neurotrophic factors in Alzheimer's disease: Role of axonal transport. Genes Brain Behav 7: 43-56.
79. Seow D, Gauthier S. 2007. Pharmacotherapy of Alzheimer disease. Can J Psychiatry 52: 620-629.
80. Sesack SR, Grace AA. 2010 Cortico-basal ganglia reward network: microcircuitry. Neuropsychopharmacology 35: 27-47.
81. Sharma A, Muresanu DF, Mossler H, Sharma HS. 2012. Superior neuroprotective effects of cerebrolysin in nanoparticle-induced exacerbation of hyperthermia-induced brain pathology. CNS Neurol Disord Drug Targets 11: 7-25.
82. Sholl DA. 1953. Dendritic organization in the neurons of the visual and motor cortices of the cat. J Anat 87: 387-406.
83. Silva-Gomez AB, Rojas D, Juarez I, Flores G. 2003. Decreased dendritic spine density on prefrontal cortical and hippocampal pyramidal neurons in postweaning social isolation rats. Brain Res 983: 128-136.
84. Solis O, Limón DI, Flores-Hernández J, Flores G. 2007. Alterations in dendritic morphology of the prefrontal cortical and striatum neurons in the unilateral 6-OHDA-rat model of Parkinson's disease. Synapse 61: 450-458.
85. Solís O, Vázquez-Roque RA, Camacho-Abrego I, Gamboa C, De La Cruz F, Zamudio S, Flores G. 2009. Decreased dendritic spine density of neurons of the prefrontal cortex and nucleus accumbens and enhanced amphetamine sensitivity in postpubertal rats after a neonatal amygdala lesion. Synapse 63: 1143-1153.
86. Steen E, Terry BM, Rivera EJ, Cannon JL, Neely TR, Tavares R, Xu XJ, Wands JR, de la Monte SM. 2005. Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease-Is this type 3 diabetes? J Alzheimers Dis 7: 63-80.
87. Stone JG, Casadesus G, Gustaw-Rothenberg K, Siedlak SL, Wang X, Zhu X, Perry G, Castellani RJ, Smith MA. 2011. Frontiers in Alzheimer's disease therapeutics. Ther Adv Chronic Dis 2: 9-23.
88. Swardfager W, Lanctot K, Rothenburg L, Wong A, Cappell J, Herrmann N. 2010. A meta-analysis of cytokines in Alzheimer's disease. Biol Psychiatry 68: 930-941.
89. Swiech L, Blazejczyk M, Urbanska M, Pietruszka P, Dortland BR, Malik AR, Wulf PS, Hoogenraad CC, Jaworski J. 2011. CLIP-170 and IQGAP1 cooperatively regulate dendrite morphology. J Neurosci 31: 4555-4568.
90. Takada-Takatori Y, Kume T, Ohgi Y, Izumi Y, Niidome T, Fujii T, Sugimoto H, Akaike A. 2008. Mechanism of neuroprotection by donepezil pretreatment in rat cortical neurons chronically treated with donepezil. J Neurosci Res 86: 3575-3583.
91. Tatebayashi Y, Lee MH, Li L, Iqbal K, Grundke-Iqbal I. 2003. The dentate gyrus neurogenesis: A therapeutic target for Alzheimer's disease. Acta Neuropathol 105: 225-232.
92. Thierry AM, Gioanni Y, Degenetais E, Glowinski J. 2000. Hippocampo-prefrontal cortex pathway: Anatomical and electrophysiological characteristics. Hippocampus 10: 411-419.
93. Tsuno N. 2009. Donepezil in the treatment of patients with Alzheimer's disease. Expert Rev Neurother 9: 591-598.
94. Vázquez-Roque RA, Ramos B, Tecuatl C, Juárez I, Adame A, de la Cruz F, Zamudio S, Mena R, Rockenstein E, Masliah E, Flores G. 2012. Chronic administration of the neurotrophic agent cerebrolysin ameliorates the behavioral and morphological changes induced by neonatal ventral hippocampus lesion in a rat model of schizophrenia. J Neurosci Res 90: 288-306.
95. Vega E, Gomez-Villalobos MJ, Flores G. 2004. Alteration in dendritic morphology of pyramidal neurons from the prefrontal cortex of rats with renovascular hypertension. Brain Res 1021: 112-118.
96. Veinbergs I, Mante M, Mallory M, Masliah E. 2000. Neurotrophic effects of Cerebrolysin in animal models of excitotoxicity. J Neural Transm Suppl 59: 273-280.
97. Wang T, Chen M, Liu L, Cheng H, Yan YE, Feng YH, Wang H. 2011. Nicotine induced CpG methylation of Pax6 binding motif in StAR promoter reduces the gene expression and cortisol production. Toxicol Appl Pharmacol 257: 328-337.
98. Webster N, Pirrung M. 2008. Small molecule activators of the Trk receptors for neuroprotection. BMC Neuroscience 9 ( Suppl 2): S1.
99. Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT, Delon MR. 1982. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science 215: 1237-1239.
100. Windholz E, Gschanes A, Windisch M, Fachbach G. 2000. Two peptidergic drugs increase the synaptophysin immunoreactivity in brains of 6-week-old rats. Histochem J 32: 79-84.
101. Wu X, Kihara T, Akaike A, Niidome T, Sugimoto H. 2010. PI3K/Akt/mTOR signaling regulates glutamate transporter 1 in astrocytes. Biochem Biophys Res Commun 393: 514-518.
102. Wyss-Coray T. 2006. Inflammation in Alzheimer disease: Driving force, bystander or beneficial response? Nat Med 12: 1005-1015.
103. Zhang C, Chopp M, Cui Y, Wang L, Zhang R, Zhang L, Lu M, Szalad A, Doppler E, Hitzl M, Zhang ZG. 2010. Cerebrolysin enhances neurogenesis in the ischemic brain and improves functional outcome after stroke. J Neurosci Res 88: 3275-3281.
104. Zuccato C, Cattaneo E. 2009. Brain-derived neurotrophic factor in neurodegenerative diseases. Nat Rev Neurol 5: 311-322.